A multicenter, randomized double-blind study of valsartan/hy... : Journal of Hypertension A
multicenter, randomized double-blind study of valsartan/hydrochlorothiazide combination …

Abstract▲ Amlodipine/valsartan/hydrochlorothiazide (HCTZ) is a fixed-dose combination of
the well established antihypertensive agents amlodipine (a calcium channel antagonist) …

Most hypertensive patients need more than one drug to reach recommended blood‐
pressure targets. We investigated the effects on 24‐h ambulatory blood pressure (ABP) of …

Many patients with hypertension require≥ 3 agents to achieve target blood pressure (BP).
The efficacy/safety of the dual combinations of valsartan (Val)/hydrochlorothiazide (HCTZ) …

A significant proportion of patients with hypertension will need three or more
antihypertensive agents to achieve blood pressure goals, particularly those at higher risk …

Objective: This study compared the efficacy and tolerability of two combination regimens of
valsartan and hydrochlorothiazide (HCTZ) with valsartan monotherapy in patients with …

Objectives. To investigate the efficacy and tolerability of valsartan (Val) 320 mg once daily
(od), Val/hydrochlorothiazide (HCTZ) 320/12.5 mg od and Val/HCTZ 320/25 mg od in …

Background: Valsartan/hydrochlorothiazide is a combination of an angiotensin II receptor
antagonist and diuretic indicated for hypertensive patients as initial therapy and those not …

Objective: This study compares the antihypertensive efficacy and tolerability of valsartan, a
novel angiotensin II antagonist, given with hydrochlorothiazide (HCTZ) vs placebo or vs …

The benefits of valsartan (Val)/hydrochlorothiazide (HCTZ) combination as initial treatment
for hypertension were evaluated in a post hoc analysis of an 8-week, double-blind, placebo …